Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia

被引：0
|
作者：
Anne Sofie Andreasen
Theis Pedersen-Skovsgaard
Ronan M. G. Berg
Kira Dynnes Svendsen
Bo Feldt-Rasmussen
Bente K. Pedersen
Kirsten Møller
机构：
[1] University Hospital Rigshospitalet,Centre of Inflammation and Metabolism, Department of Infectious Diseases
[2] University Hospital Rigshospitalet,Intensive Care Unit 4131
[3] University of Copenhagen,Department of Biostatistics
[4] University Hospital Rigshospitalet,Department of Nephrology
来源：
Intensive Care Medicine | 2010年 / 36卷
关键词：
Type 2 diabetes; Sepsis; Inflammation; LPS; Cytokines; Adhesion molecules;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1548 / 1555
页数：7
相关论文
共 50 条
  • [41] Correlation between inflammatory markers and impaired circadian clock gene expression in type 2 diabetes mellitus
    Yu, Rongguo
    Tian, Linlin
    Ding, Yi
    Gao, Yali
    Li, Daiqing
    Tang, Yunzhao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 156
  • [42] Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus
    Henkel, E
    Menschikowski, M
    Koehler, C
    Leonhardt, W
    Hanefeld, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (09): : 1168 - 1173
  • [43] IMPAIRED ORTHOSTATIC RESPONSE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AFTER 48 HOURS OF BED REST
    Schneider, Suzanne M.
    Robergs, Robert A.
    Amorim, Fabiano T.
    de Serna, Daniela Gonzalez
    Duran-Valdez, Elizabeth E.
    Schade, David S.
    ENDOCRINE PRACTICE, 2009, 15 (02) : 104 - 110
  • [44] Impaired Myocardial Response to Glucagon-Like Peptide 1 in Humans With Type 2 Diabetes Mellitus
    Moberly, Steven P.
    Hutchins, Gary D.
    Tune, Johnathan D.
    Perry, Kevin
    Chisholm, Robin L.
    Considine, Robert V.
    Mather, Kieren J.
    DIABETES, 2012, 61 : A475 - A475
  • [45] Prothrombotic State Is Associated with Impaired Arterial Wall Elastic Properties in Patients with Type 2 Diabetes Mellitus
    Siasos, Gerasimos
    Stampouloglou, Panagiota K.
    Bletsa, Evanthia
    Batzias, Konstantinos
    Paschou, Stavroula A.
    Antonopoulos, Alexios
    Tsigkou, Vasiliki
    Gouliopoulos, Nikolaos
    Zaromytidou, Marina
    Mazaris, Savvas, Sr.
    Oikonomou, Evangelos
    Tsalamandris, Sotiris
    Vogiatzi, Georgia
    Thanopoulou, Anastasia
    Vryonidou, Andromachi
    Politou, Marianna
    Tousoulis, Dimitris
    Tentolouris, Nikolas
    DIABETES, 2019, 68
  • [46] Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus
    Zhou, Huali
    Shiu, Sammy W. M.
    Wong, Ying
    Tan, Kathryn C. B.
    DIABETES & VASCULAR DISEASE RESEARCH, 2009, 6 (04): : 238 - 243
  • [47] Impaired erythropoietin response to hypoxia in type 2 diabetes
    Wojan, Frank
    Stray-Gundersen, Sten
    Zhao, Jiahui
    Lalande, Sophie
    ACTA DIABETOLOGICA, 2024, 61 (07) : 925 - 932
  • [48] Relationship between impaired parasympathetic vasodilation and hyposalivation in parotid glands associated with type 2 diabetes mellitus
    Sato, Toshiya
    Mito, Kohei
    Ishii, Hisayoshi
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2020, 318 (05) : R940 - R949
  • [49] Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline
    Ben Assayag, Einor
    Eldor, Roy
    Korczyn, Amos D.
    Kliper, Efrat
    Shenhar-Tsarfaty, Shani
    Tene, Oren
    Molad, Jeremy
    Shapira, Itzhak
    Berliner, Shlomo
    Volfson, Viki
    Shopin, Ludmila
    Strauss, Yehuda
    Hallevi, Hen
    Bornstein, Natan M.
    Auriel, Eitan
    STROKE, 2017, 48 (09) : 2368 - +
  • [50] Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus
    Goya, K
    Otsuki, M
    Xu, X
    Kasayama, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (02): : 192 - 198
12345